BRPI0408972A - composto, formulação, uso de um composto, e, processo para a preparação de um éster de polioxialquileno glicol - Google Patents

composto, formulação, uso de um composto, e, processo para a preparação de um éster de polioxialquileno glicol

Info

Publication number
BRPI0408972A
BRPI0408972A BRPI0408972-3A BRPI0408972A BRPI0408972A BR PI0408972 A BRPI0408972 A BR PI0408972A BR PI0408972 A BRPI0408972 A BR PI0408972A BR PI0408972 A BRPI0408972 A BR PI0408972A
Authority
BR
Brazil
Prior art keywords
compound
preparation
polyoxyalkylene glycol
polyoxyalkylene
fatty acid
Prior art date
Application number
BRPI0408972-3A
Other languages
English (en)
Inventor
Christian Von Corswant
Karl Hult
Erik Soederlind
Fredrik Viklund
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BRPI0408972A publication Critical patent/BRPI0408972A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
    • C08G65/3322—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof acyclic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polyethers (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

"COMPOSTO, FORMULAçãO, USO DE UM COMPOSTO, E, PROCESSO PARA A PREPARAçãO DE UM éSTER DE POLIOXIALQUILENO GLICOL". Tensoativos novos não iónicos na forma de derivados de ácido hidróxi graxo polioxialquileno glicol ou derivados de ácido hidróxi graxo polioxialquileno glicol monoalquilado tendo uma cadeia de polioxialquileno/ alquil polioxialquileno com um comprimento de cadeia de 25 - 455 unidades de repetição e um substituinte especificado na posição hidroxila do ácido hidróxi graxo especificado, de acordo com a fórmula geral (I) onde, por exemplo, R~ 1~, é metila, R~ 2~ é acila, alquila, ou alquenila C~ 14~-C~ 22~ opcionalmente substituido, R~ 3~ é etileno, x é 2 - 12, y é 7 17, (x + y) é 3 - 19 e z é 25 - 57; preparado vantajosamente através do envolvimento de um processo enzimático, as formulações compostas dos mesmos, o seu uso como solubilizante em um processo envolvendo uma enzima hidrolítica para a preparação dos mesmos.
BRPI0408972-3A 2003-04-14 2004-04-13 composto, formulação, uso de um composto, e, processo para a preparação de um éster de polioxialquileno glicol BRPI0408972A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0301119A SE0301119D0 (sv) 2003-04-14 2003-04-14 New non-ionic surfactants for solubilizing poorly soluble molecules
PCT/SE2004/000572 WO2004089869A1 (en) 2003-04-14 2004-04-13 New non-ionic surfactants for solubilizing poorly soluble molecules

Publications (1)

Publication Number Publication Date
BRPI0408972A true BRPI0408972A (pt) 2006-04-04

Family

ID=20291043

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408972-3A BRPI0408972A (pt) 2003-04-14 2004-04-13 composto, formulação, uso de um composto, e, processo para a preparação de um éster de polioxialquileno glicol

Country Status (16)

Country Link
US (1) US7491836B2 (pt)
EP (1) EP1615874B1 (pt)
JP (1) JP4589917B2 (pt)
KR (1) KR101091324B1 (pt)
CN (1) CN1774414B (pt)
AU (1) AU2004228602B2 (pt)
BR (1) BRPI0408972A (pt)
CA (1) CA2521612C (pt)
ES (1) ES2445821T3 (pt)
IL (1) IL171058A (pt)
MX (1) MXPA05010893A (pt)
NO (1) NO20055331L (pt)
NZ (1) NZ542752A (pt)
SE (1) SE0301119D0 (pt)
WO (1) WO2004089869A1 (pt)
ZA (1) ZA200508247B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090280429A1 (en) * 2008-05-08 2009-11-12 Xerox Corporation Polyester synthesis
GB201115634D0 (en) * 2011-09-09 2011-10-26 Univ Liverpool Compositions of lopinavir
EP2844303B1 (en) * 2012-05-03 2021-09-15 Beth Israel Deaconess Medical Center, Inc. Lipids that increase insulin sensitivity and methods of using the same
US10604473B2 (en) 2013-03-15 2020-03-31 Beth Israel Deaconess Medical Center, Inc. Lipids that increase insulin sensitivity and methods of using the same
US9284583B2 (en) * 2014-07-16 2016-03-15 Eastman Chemical Company Enzyme-catalyzed polyoxyalkylene esters
WO2017214527A1 (en) 2016-06-10 2017-12-14 Beth Israel Deaconess Medical Center, Inc. Fatty acid esters of hydroxy fatty acids (fahfas) for use in the treatment of type 1 diabetes
CN107664676A (zh) * 2016-07-29 2018-02-06 中国石油化工股份有限公司 基于增粘型乳液增溶水速率分析方法
CA3111693A1 (en) * 2018-09-05 2020-03-12 Lonza Guangzhou Nansha Ltd. Method for making polyoxyethylene 1,4 sorbitan fatty acid ester
WO2025243208A2 (en) * 2024-05-20 2025-11-27 Hovione - Farmaciência, Sa Process for the preparation and/or purification of polyethylene glycol and its derivatives, obtained product and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2911241A1 (de) * 1979-03-22 1980-10-02 Basf Ag Alkoxylierte fettsaeuren, verfahren zu deren herstellung und ihre anwendung als loesungsvermittler
JPS5969135A (ja) 1982-10-12 1984-04-19 Nippon Oil & Fats Co Ltd 可溶化または乳化剤
JPS61187795A (ja) * 1985-02-15 1986-08-21 Dai Ichi Kogyo Seiyaku Co Ltd ポリグリセリン脂肪酸エステルの製造法
ATE218359T1 (de) * 1994-11-03 2002-06-15 Novartis Erfind Verwalt Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
JP3533043B2 (ja) * 1995-06-19 2004-05-31 三菱化学株式会社 ポリグリセリン脂肪酸エステルの曇点測定方法、該方法を用いる物性評価及び製造方法。
FR2746106B1 (fr) * 1996-03-15 1998-08-28 Combustible emulsionne et l'un de ses procedes d'obtention
JP3610509B2 (ja) * 1996-03-26 2005-01-12 サンノプコ株式会社 消泡剤
DE19622214C2 (de) * 1996-06-03 2000-09-28 Cognis Deutschland Gmbh Verwendung von Hydroxycarbonsäureestern
DE19851777A1 (de) * 1998-11-10 2000-05-11 Basf Ag Verwendung von Estern oder Amiden hydroxylierter Carbonsäuren als Solubilisatoren

Also Published As

Publication number Publication date
IL171058A (en) 2011-04-28
WO2004089869A1 (en) 2004-10-21
ES2445821T3 (es) 2014-03-05
AU2004228602A1 (en) 2004-10-21
US7491836B2 (en) 2009-02-17
CN1774414B (zh) 2010-12-08
NO20055331D0 (no) 2005-11-11
NO20055331L (no) 2006-01-16
CA2521612A1 (en) 2004-10-21
KR101091324B1 (ko) 2011-12-07
EP1615874A1 (en) 2006-01-18
NZ542752A (en) 2007-05-31
HK1089747A1 (en) 2006-12-08
CN1774414A (zh) 2006-05-17
EP1615874B1 (en) 2013-12-25
SE0301119D0 (sv) 2003-04-14
US20060287542A1 (en) 2006-12-21
MXPA05010893A (es) 2005-11-25
KR20060004937A (ko) 2006-01-16
CA2521612C (en) 2012-02-07
JP2006526048A (ja) 2006-11-16
ZA200508247B (en) 2007-03-28
AU2004228602B2 (en) 2007-06-14
JP4589917B2 (ja) 2010-12-01

Similar Documents

Publication Publication Date Title
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
BRPI0714358B8 (pt) processo para fabricação de um lactil lactato de alquila
PE46499A1 (es) Derivados de 6-fenilpiridil-2-amina
BRPI0411197A (pt) éter de celulose, processo para produzì-lo, e composições para cuidado pessoal e para cuidado dos cabelos ou pele
BR0214142A (pt) Derivados e intermediários de n-adamantilmetila como composições farmacêuticas e processos para sua preparação
DK76889D0 (da) Fremgangsmaade til fremstilling af organiske forbindelser
ATE451351T1 (de) Vitamin-d-analogon nel, verfahren und seine verwendung
BR0109882A (pt) Alcoxilato de álcool ou uma mistura do mesmo, processo para a preparação dos mesmos, uso dos mesmos, e, detergente e limpador
MY154966A (en) Low foaming cleaner
BRPI0507862A (pt) processo para a alcoxilação de alquil- e/ou alquenilpoliglicosìdeos
BRPI0909055A2 (pt) composto derivado de piridin-2-il, composição farmacêutica que o contém e uso desse composto.
BR0111047A (pt) Uma microemulsão contendo um alquil glicosìdeo ramificado
BR112023003599A2 (pt) Novo composto derivado de soforolipídeo
DK1230330T3 (da) Anvendelse af fedtsyresalte af alkoxylerede oligoaminer som smöreevneforbedrende midler til mineralprodukter
AR063894A1 (es) Uso de un acido indazolmetoxialcanoico para preparar una composicion farmaceutica
BR9812808A (pt) 3,6-hemicetais da classe de 9a-azalidas, processo para preparação dos mesmos, seuuso farmacêutico, bem como composição farmacêutica compreendendo os mesmos
SE0301119D0 (sv) New non-ionic surfactants for solubilizing poorly soluble molecules
DE50004002D1 (de) Dithiocarbamat-flüssigformulierungen
ATE118758T1 (de) Derivate von endogenen mediatoren, ihre salze, verfahren zur herstellung, anwendungen und zusammensetzungen, die diese enthalten.
BRPI0208367B8 (pt) composição farmacêutica para o tratamento de infecções oculares, para aplicação local, processo para a preparação de uma composição farmacêutica de colírio, adequada para aplicação local em oftalmologia, e, utilização de azitromicina
WO2008035228A3 (en) 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof
IT1313617B1 (it) Processo per la preparazione di derivati degli acidi biliari.
KR890000427A (ko) 아미노시클로펜틸 에테르 및 그의 제조방법 및 약제
FR2816505B1 (fr) Utilisation de carbohydrate pour ameliorer la fonction barriere de la peau
BRPI0415802A (pt) composição de condicionamento dos cabelos, método para preparar uma composição opacificada de condicionamento dos cabelos e método para o tratamento dos cabelos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.